Literature DB >> 1577874

Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells.

S C Wright1, P Kumar, A W Tam, N Shen, M Varma, J W Larrick.   

Abstract

The hypothesis that activation of apoptosis and DNA fragmentation is involved in TNF-mediated cytolysis of U937 tumor cells was investigated. Morphological, biochemical, and kinetic criteria established that TNF activates apoptosis as opposed to necrosis. Within 2-3 h of exposure to TNF, U937 underwent the morphological alterations characteristic of apoptosis. This was accompanied by cleavage of DNA into multiples of nucleosome size fragments. Both of these events occurred 1-2 h prior to cell death as defined by trypan blue exclusion or 51Cr release. DNA fragmentation was not a non-specific result of cell death since U937 cells lysed under hypotonic conditions did not release DNA fragments. The percentage of cells undergoing apoptosis depended on the concentration of TNF and was augmented by the addition of cycloheximide. A TNF-resistant variant derived from U937 did not undergo apoptosis in response to TNF, even in the presence of cycloheximide. Furthermore, TNF could still activate NFkB in this variant, suggesting that this pathway is not involved in TNF-mediated cytotoxicity. Two agents known to inhibit TNF-mediated cytotoxicity, ZnSO4 and 3-aminobenzamide, were shown to inhibit TNF-induced apoptosis. Taken altogether, these data support the hypothesis that activation of apoptosis is at least one essential step in the TNF lytic pathway in the U937 model system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577874     DOI: 10.1002/jcb.240480403

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  25 in total

Review 1.  Poly(ADP-ribosylation) and apoptosis.

Authors:  A I Scovassi; G G Poirier
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2.

Authors:  H Iwahashi; T Hanafusa; Y Eguchi; H Nakajima; J Miyagawa; N Itoh; K Tomita; M Namba; M Kuwajima; T Noguchi; Y Tsujimoto; Y Matsuzawa
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

3.  Binding of tumour necrosis factor-alpha (TNF-alpha) to TNF-RI induces caspase(s)-dependent apoptosis in human cholangiocarcinoma cell lines.

Authors:  P Utaisincharoen; S Ubol; N Tangthawornchaikul; P Chaisuriya; S Sirisinha
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 4.  Potential roles for tumour necrosis factor alpha during embryonic development.

Authors:  M A Wride; E J Sanders
Journal:  Anat Embryol (Berl)       Date:  1995-01

Review 5.  Programmed cell death--many questions still to be answered.

Authors:  C Binder; W Hiddemann
Journal:  Ann Hematol       Date:  1994-08       Impact factor: 3.673

6.  Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.

Authors:  Jinghua Jia; Yanping Wang; Lei Zhou; Shouguang Jin
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

7.  Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha.

Authors:  L P Deiss; H Galinka; H Berissi; O Cohen; A Kimchi
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

8.  Ceramide induces apoptosis to immature cerebellar granule cells in culture.

Authors:  T Taniwaki; T Yamada; H Asahara; Y Ohyagi; J Kira
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

Review 9.  Differentiation, apoptosis, and function of human immature and mature myeloid cells: intracellular signaling mechanism.

Authors:  Akira Yuo
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

10.  Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway.

Authors:  W D Jarvis; R N Kolesnick; F A Fornari; R S Traylor; D A Gewirtz; S Grant
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.